- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prophylaxis of migraine
- Meeting Date: July 2023
- Public Summary Document (PSD) July 2023 PBAC Meeting - (PDF 910KB)
- Public Summary Document (PSD) July 2023 PBAC Meeting - (Word 503KB)
Atogepant – July 2023
Atogepant: Tablet 60 mg; Aquipta® - July 2023
Last updated
10 November 2023